These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18431898)

  • 21. Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: a pilot study.
    Carmagnola D; Celestino S; Abati S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):e10-5. PubMed ID: 18801674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management.
    Montebugnoli L; Felicetti L; Gissi DB; Pizzigallo A; Pelliccioni GA; Marchetti C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Oct; 104(4):473-7. PubMed ID: 17482847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for bisphosphonate-related osteonecrosis of the jaws.
    Fleisher KE; Glickman RS
    J Oral Maxillofac Surg; 2011 Apr; 69(4):959; author reply 959-60. PubMed ID: 21440820
    [No Abstract]   [Full Text] [Related]  

  • 24. Bisphosphonate-associated osteonecrosis: experiences in a private practice.
    Marder MZ; Marder RW
    Dent Today; 2008 Oct; 27(10):99-100, 102-3; quiz 103, 98. PubMed ID: 18935863
    [No Abstract]   [Full Text] [Related]  

  • 25. Osteonecrosis of the jaw and bisphosphonates.
    Maerevoet M; Martin C; Duck L
    N Engl J Med; 2005 Jul; 353(1):99-102; discussion 99-102. PubMed ID: 16003838
    [No Abstract]   [Full Text] [Related]  

  • 26. Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats.
    Maahs MP; Azambuja AA; Campos MM; Salum FG; Cherubini K
    Head Neck; 2011 Feb; 33(2):199-207. PubMed ID: 20848442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zoledronic acid and osteonecrosis of the jaw: incidence varies with use.
    Wynn RL
    Gen Dent; 2011; 59(5):330-2. PubMed ID: 22313815
    [No Abstract]   [Full Text] [Related]  

  • 28. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
    Chu V; ;
    Hawaii Dent J; 2008; 39(5):9-12; quiz 17. PubMed ID: 19189512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bisphosphonates--role in cancer therapies.
    Mehrotra B
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral osteonecrosis associated with the use of zoledronic acid: first case of a patient with advanced pancreatic cancer and bone metastases.
    Smith A; Kressley A; Saif MW
    JOP; 2009 Mar; 10(2):212-4. PubMed ID: 19287122
    [No Abstract]   [Full Text] [Related]  

  • 31. Comments on "Osteonecrosis of the jaws in intravenous bisphosphonate use: proposal for a modification of the clinical classification".
    Woo SB; Mawardi H; Treister N
    Oral Oncol; 2009 Aug; 45(8):740. PubMed ID: 19038574
    [No Abstract]   [Full Text] [Related]  

  • 32. [Osteonecrosis of the jaw following complex tumour treatment using bisphosphonates].
    Machálka M
    Vnitr Lek; 2006 Nov; 52 Suppl 2():79, 81-2. PubMed ID: 18181284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editorial: bisphosphonates.
    Reid RJ
    Aust Endod J; 2007 Aug; 33(2):53-4. PubMed ID: 17697244
    [No Abstract]   [Full Text] [Related]  

  • 34. Bisphosphonate-associated osteonecrosis of the jaw 2 years after teeth extractions: a case report solved with non-invasive treatment.
    Gómez-Moreno G; Arribas-Fernández MC; Fernández-Guerrero M; Boquete-Castro A; Aguilar-Salvatierra A; Guardia J; Botticelli D; Calvo-Guirado JL
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1391-7. PubMed ID: 24867519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone.
    Tosi P; Zamagni E; Cangini D; Tacchetti P; Di Raimondo F; Catalano L; D'Arco A; Ronconi S; Cellini C; Offidani M; Perrone G; Ceccolini M; Brioli A; Tura S; Baccarani M; Cavo M
    Blood; 2006 Dec; 108(12):3951-2. PubMed ID: 17114572
    [No Abstract]   [Full Text] [Related]  

  • 36. Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients.
    Kyrgidis A; Vahtsevanos K; Koloutsos G; Andreadis C; Boukovinas I; Teleioudis Z; Patrikidou A; Triaridis S
    J Clin Oncol; 2008 Oct; 26(28):4634-8. PubMed ID: 18574158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bisphosphonate induced osteochemonecrosis of the jaw mimicking a tumour.
    Pancholi M; Edwards A; Langton S
    Br Dent J; 2007 Jul; 203(2):87-9. PubMed ID: 17660778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diabetes mellitus and bisphosphonate-related osteonecrosis of the jaws].
    Urade M
    Clin Calcium; 2009 Sep; 19(9):1332-8. PubMed ID: 19721206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?
    Junquera L; Gallego L
    J Oral Maxillofac Surg; 2008 Jul; 66(7):1516-7. PubMed ID: 18571043
    [No Abstract]   [Full Text] [Related]  

  • 40. Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates.
    Grasko JM; Herrmann RP; Vasikaran SD
    J Oral Maxillofac Surg; 2009 Mar; 67(3):645-9. PubMed ID: 19231794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.